Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Reviva Pharmaceuticals Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +4 vs. Q2 2024
- Shares held
- 9.95M
- +3.21M (+47.7%) vs. Q2 2024
- Total value
- $14.3M
- +$5.70M (+66.2%) vs. Q2 2024
- New holders
- 9
- 8 more added
- Sold out
- 5
- 7 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $3.67K |
| Q1 2026 | 35 | $2.13M |
| Q4 2025 | 48 | $3.17M |
| Q3 2025 | 42 | $3.52M |
| Q2 2025 | 46 | $5.44M |
| Q1 2025 | 49 | $6.95M |
| Q4 2024 | 42 | $14.0M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 31 | $8.75M |
| Q1 2024 | 28 | $21.0M |
| Q4 2023 | 36 | $27.1M |
| Q3 2023 | 24 | $13.0M |
| Q2 2023 | 23 | $15.5M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 23 | $5.54M |
| Q3 2022 | 19 | $1.65M |
| Q2 2022 | 13 | $2.05M |
| Q1 2022 | 16 | $4.68M |
| Q4 2021 | 14 | $7.54M |
| Q3 2021 | 12 | $10.5M |
| Q2 2021 | 12 | $12.8M |
| Q1 2021 | 8 | $3.37M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Reviva Pharmaceuticals Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,186,000 | $4.59M | 0.12% | +3,186,000 | New |
| Millennium Management LLC | 1,832,814 | $2.64M | 0.00% | +591,321+47.6% | Added |
| Schonfeld Strategic Advisors LLC | 1,515,900 | $2.18M | 0.02% | +502,109+49.5% | Added |
| Vanguard Group Inc | 1,025,249 | $1.48M | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 684,805 | $986.1K | 0.01% | −907,983−57.0% | Reduced |
| Parkman Healthcare Partners LLC | 512,202 | $737.6K | 0.09% | +7,602+1.5% | Added |
| Geode Capital Management, LLC | 278,496 | $401.1K | 0.00% | +42,376+17.9% | Added |
| Colony Group, LLC | 161,000 | $231.8K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 154,800 | $222.9K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 104,690 | $150.8K | 0.00% | +104,690 | New |
| Group One Trading, L.P. | 75,573 | $108.8K | 0.00% | +46,181+157.1% | Added |
| State Street Corp | 71,400 | $102.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 63,169 | $91.0K | 0.00% | +22,157+54.0% | Added |
| Avantax Advisory Services, Inc. | 60,000 | $86.4K | 0.00% | +60,000 | New |
| Northern Trust Corp | 57,747 | $83.2K | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 30,000 | $43.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 21,369 | $30.8K | 0.00% | −9,699−31.2% | Reduced |
| Virtu Financial LLC | 14,266 | $21.0K | 0.00% | +14,266 | New |
| Two Sigma Securities, LLC | 13,944 | $20.1K | 0.00% | +13,944 | New |
| Citadel Advisors LLC | 13,508 | $19.5K | 0.00% | +13,508 | New |
| Commonwealth Equity Services, LLC | 12,342 | $18.0K | 0.00% | +12,342 | New |
| BluePointe Capital Management, LLC | 10,378 | $14.9K | 0.01% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 9,299 | $13.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,120 | $8.81K | 0.00% | −11,806−65.9% | Reduced |
| Wolverine Asset Management LLC | 3,555 | $5.12K | 0.00% | −975−21.5% | Reduced |
| Tower Research Capital LLC (TRC) | 2,822 | $4.06K | 0.00% | +2,432+623.6% | Added |
| UBS Group AG | 2,313 | $3.33K | 0.00% | −130,127−98.3% | Reduced |
| Deutsche Bank AG | 2,000 | $2.88K | 0.00% | +2,000 | New |
| Godsey & Gibb Associates | 1,600 | $2.30K | 0.00% | +1,600 | New |
| Activest Wealth Management | 1,000 | $1.44K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 250 | $360 | 0.00% | +125+100.0% | Added |
| Bank of America Corp | 215 | $310 | 0.00% | −3,730−94.6% | Reduced |
| EMC Capital Management | 18,401 | – | – | −105,514−85.2% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −236,997−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,420−100.0% | Sold out |
| Archer Investment Corp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| NRI Wealth Management LC | – | – | – | – | Not filed |